288 related articles for article (PubMed ID: 23006327)
21. The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.
Clémenceau B; Vivien R; Pellat C; Foss M; Thibault G; Vié H
MAbs; 2013; 5(4):587-94. PubMed ID: 23770975
[TBL] [Abstract][Full Text] [Related]
22. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
Chen Y; You F; Jiang L; Li J; Zhu X; Bao Y; Sun X; Tang X; Meng H; An G; Zhang B; Yang L
Oncotarget; 2017 Jun; 8(23):37128-37139. PubMed ID: 28415754
[TBL] [Abstract][Full Text] [Related]
23. TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer.
Wong JKM; McCulloch TR; Alim L; Omer N; Mehdi AM; Tuong ZK; Bonfim-Melo A; Chung E; Nicol A; Simpson F; Rhee H; Rossi GR; Souza-Fonseca-Guimaraes F
EBioMedicine; 2024 Jun; 104():105176. PubMed ID: 38810560
[TBL] [Abstract][Full Text] [Related]
24. Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.
Liu LL; Landskron J; Ask EH; Enqvist M; Sohlberg E; Traherne JA; Hammer Q; Goodridge JP; Larsson S; Jayaraman J; Oei VYS; Schaffer M; Taskén K; Ljunggren HG; Romagnani C; Trowsdale J; Malmberg KJ; Béziat V
Cell Rep; 2016 May; 15(5):1088-1099. PubMed ID: 27117418
[TBL] [Abstract][Full Text] [Related]
25. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
Isitman G; Tremblay-McLean A; Lisovsky I; Bruneau J; Lebouché B; Routy JP; Bernard NF
PLoS One; 2016; 11(10):e0164517. PubMed ID: 27732638
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.
Liu Q; Sun Y; Rihn S; Nolting A; Tsoukas PN; Jost S; Cohen K; Walker B; Alter G
J Virol; 2009 Sep; 83(17):8705-12. PubMed ID: 19553339
[TBL] [Abstract][Full Text] [Related]
27. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells.
Srpan K; Ambrose A; Karampatzakis A; Saeed M; Cartwright ANR; Guldevall K; De Matos GDSC; Önfelt B; Davis DM
J Cell Biol; 2018 Sep; 217(9):3267-3283. PubMed ID: 29967280
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
Trotta R; Dal Col J; Yu J; Ciarlariello D; Thomas B; Zhang X; Allard J; Wei M; Mao H; Byrd JC; Perrotti D; Caligiuri MA
J Immunol; 2008 Sep; 181(6):3784-92. PubMed ID: 18768831
[TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer.
Clémenceau B; Valsesia-Wittmann S; Jallas AC; Vivien R; Rousseau R; Marabelle A; Caux C; Vié H
J Immunol Res; 2015; 2015():482089. PubMed ID: 26665156
[TBL] [Abstract][Full Text] [Related]
30. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets.
Carver FM; Thomas JM
Cell Immunol; 1988 Nov; 117(1):56-69. PubMed ID: 2902933
[TBL] [Abstract][Full Text] [Related]
32. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification.
Clémenceau B; Vivien R; Debeaupuis E; Esbelin J; Biron C; Levy Y; Vié H
J Immunother; 2011 Sep; 34(7):542-9. PubMed ID: 21760529
[TBL] [Abstract][Full Text] [Related]
33. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.
Mandelboim O; Malik P; Davis DM; Jo CH; Boyson JE; Strominger JL
Proc Natl Acad Sci U S A; 1999 May; 96(10):5640-4. PubMed ID: 10318937
[TBL] [Abstract][Full Text] [Related]
34. The two-pore domain K2 P channel TASK2 drives human NK-cell proliferation and cytolytic function.
Schulte-Mecklenbeck A; Bittner S; Ehling P; Döring F; Wischmeyer E; Breuer J; Herrmann AM; Wiendl H; Meuth SG; Gross CC
Eur J Immunol; 2015 Sep; 45(9):2602-14. PubMed ID: 26140335
[TBL] [Abstract][Full Text] [Related]
35. Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells.
da Silva AJ; Brickelmaier M; Majeau GR; Li Z; Su L; Hsu YM; Hochman PS
J Immunol; 2002 May; 168(9):4462-71. PubMed ID: 11970990
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in the FcgammaRIIIA gene (CD16) results in active natural killer cells lacking CD16.
Takeuchi T; Nakagawa T; Ikemoto T; Sasaki M; Makino S; Shimizu A; Ohsawa N
Autoimmunity; 1999; 31(4):265-71. PubMed ID: 10789992
[TBL] [Abstract][Full Text] [Related]
37. NK cell degranulation as a marker for measuring antibody-dependent cytotoxicity in neutralizing and non-neutralizing human sera from dengue patients.
Sun P; Morrison BJ; Beckett CG; Liang Z; Nagabhushana N; Li A; Porter KR; Williams M
J Immunol Methods; 2017 Feb; 441():24-30. PubMed ID: 27856192
[TBL] [Abstract][Full Text] [Related]
38. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
[TBL] [Abstract][Full Text] [Related]
39. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
Front Immunol; 2018; 9():3124. PubMed ID: 30761158
[TBL] [Abstract][Full Text] [Related]
40. Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16).
Spruyt LL; Glennie MJ; Beyers AD; Williams AF
J Exp Med; 1991 Dec; 174(6):1407-15. PubMed ID: 1683892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
